In June 2019，Taimei Technology and Softium Technology jointly announced that the companies have achieved a final agreement that Taimei Technology will acquire Softium. Meanwhile, Softium will retain its own brand and continue to operate as a separate legal entity.. Mr. Shenjia Li will continue to be the general manager of Softium and join the senior management team of Taimei Technology Group.
Byjoining forces with Softium, Taimei Technology will provide customers with complete technology and service solutions for pharmaceutical R&D, professional operations and marketing, maximizing the operational efficiency of pharmaceutical companies, optimizing cost structure, and maintaining the competitive superiority.
“Working with Softium is an important measure for Taimei to realize the mission of offering effective HIT support for pharmaceutical industry. Dedicated to different subdivisions, they have the same belief in technology, simple corporate culture, and the expectations for the future, which are foundations for the cooperation. We will promote the informatization process of the pharmaceutical industry through the integration and sharing of professional knowledge, technical capabilities and industry resources, thereby accelerating drug discovery and new drug launch, and ultimately improving the availability of patients’ medications, “Said Zhao Lu, Chairman and CEO of Taimei Technology.